openPR Logo
Press release

Will FDA’s Endorsement of CBD-based Drugs Spur Cannabidiol Sales?

01-18-2019 03:04 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Fact.MR

Will FDA’s Endorsement of CBD-based Drugs Spur Cannabidiol

The cannabidiol marketplace is likely to witness significant R&D investment in the pharmaceutical industry as a broad-spectrum pharmaceutical therapeutics. Multiple scientific studies have shown promising results of cannabidiol for its potential in the treatment of a number of diseases. Following which the cannabidiol market is marked by a considerable cannabidiol therapeutics getting FDA approval or moving ahead in the human clinical trials. For instance, INSYS Therapeutics, Inc. announced in March 2018, the initiation of Phase III clinical trial of cannabidiol oral solution for the treatment of a rare type of pediatric epilepsy, infantile spasms. GW Pharmaceutical plc and Greenwich Biosciences, GW’s subsidiary announced FDA’s approval of EPIDIOLEX® cannabidiol oral solution in June 2018 and from November 2018, the plant-derived cannabidiol is available by prescription in the U.S.

Approval of EPIDIOLEX® cannabidiol has become a landmark announcement as it is FDA’s very first approval of the drug derived from cannabis sativa plant and also validated some of the therapeutic benefits of cannabidiol. Further, the approval is expected to impact significant economic, political and legislative shifts across the global cannabinoid marketplace. Also, the Drug Enforcement Administration (DEA) is also expected to reschedule and change the classification of cannabidiol compound in the near future.

Claim Sample Report For FREE: https://www.factmr.com/connectus/sample?flag=S&rep_id=735 

Increasing CBD Sales: Regulatory Changes Regarding Industrial Hemp to Reduce THC Content & Cost of CBD

Cannabidiol (CBD) is a non-intoxicating and non-psychotropic cannabinoid, which not only imparts myriad beneficial health effects, but also is deprived of relevant side effects. CBD is industrial hemp’s primary cannabinoid, present in concentrations between the range 0.5% and 4%. Major stakeholders in the hemp industry have been focusing on continued growth, in tandem with progress being made in legislature and product development.

The Industrial Hemp Regulations (IHR) address specific topics apropos of the production, processing, control, and export measures within various stages of the industry. Current IHR require two conformances namely, tetrahydrocannabinol (THC) testing of every field, except cultivars depicting low THC in provided province, and THC sampling & testing in production process concerning food derivatives. These process are expensive and entail the need for significant administrative investments by health regulatory bodies.

Recognizing the concern, the Canadian Hemp Trade Alliance (CHTA) proposed an efficient infield science-based alternative for generating reliable results. The proposal involves elimination of THC testing with respect to food derivatives. The alterations suggested are expected to aid achieving the objective of reducing THC content in crops with relatively less investment. Such regulatory changes are further expected to facilitate harvest, processing, and sales of non-psychoactive cannabinoids such as CBD from industrial hemp.

Request Full Report With TOC: https://www.factmr.com/connectus/sample?flag=T&rep_id=735 

Improving Accessibility to CBD-based Therapies: WHO Report aids Alleviation of Restrictions on Cannabidiol

Cannabis comprises over 100 chemical compounds known as cannabinoids, with the most common among them being CBD and THC. The WHO’s Expert Committee on Drug Dependence (ECDD) published a report in 2017, which acknowledges clinical employment of CBD to be the most advanced treatment of epilepsy.

CBD is perceived to have significant therapeutic value for seizures on account of epilepsy and relevant conditions. In addition, clinical trials conducted on CBD have depicted its efficacy in treatment of various forms of epilepsy. The report further acknowledged existence of primary evidence underpinning utilization of CBD in treatment and management of various other diseases that include Alzheimer’s disease, multiple sclerosis, Parkinson’s disease, rheumatoid arthritis, Crohn’s disease and Huntington’s disease.

ECDD’s conclusion states that current state of research with regard to scheduling of CBD is not justified, and it could impact accessibility for medical and scientific research. ECDD’s impending final recommendations, to be published soon, will reaffirm or reinforce these conclusions, in order to alleviate legitimate basis for Secretary of Department of Health in maintaining present restrictions on CBD. This will not only relieve burden from companies developing medicinal products, but also improve access for consumers to effective and novel therapies.

Cannabidiol Market: Surging Penetration in Health Food Products

Rich in alpha-linoleic, linoleic, and antioxidants, CBD oil illustrates optimal ratio of Omega-6 and Omega-3 fatty acids. Numerous studies underpin the fact that properties of CBD assist management of depression & anxiety, pain, seizures, and insomnia. As researchers continue to analyze this increasingly popular cannabinoid, consumers across the globe are becoming more aware of the therapeutic qualities associated with CBD.

Based on preferences, circumstances, and conditions of an individual, there are various ways in which CBD can be consumed, with some of the valid options being vaping CBD oil, applying CBD ointment topically, and swallowing CBD capsules. Currently, more and more individuals are seeking incorporation of CBD into their lifestyle through infusion into their meals.

CBD-infused food products are gaining high momentum in the market, abreast growing consumer demand for healthy food options. In response to growing demand, companies are concentrating on production of healthy foods for meeting requirements of consumers seeking healthy replacements for traditional CBD-infused foods. Some of the common examples of such healthy alternatives include essential oil blends, flavored tinctures, and edibles such as coffee and candy.

Notable Developments in CBD Market

Pivot Pharmaceuticals Inc., in coordination with SolMic GmbH, its German technology partner, announced the initiation of its development of PGS-N001 in 2017. PGS-N001 is a water-soluble, natural, and pure oral CBD solution, which shows highest bioavailability and is devoid of THC. PGS-N001 will be developed and formulated for treating a wide range of disease indications such as the chemotherapy-induced nausea and vomiting (CINV) – major therapeutic challenge in cancer supportive care area.
Nightfood Holdings, a startup that manufactures and markets products in nighttime snacking category, entered into a joint venture with Player’s Network Inc. in 2017. This joint venture is dedicated toward the development of CBD-infused line of products such as cannabinoid oil.
Marijuana Company of America, Inc. (MCOA) has partnered with HoneyB Healthy Living for developing a series of CBD-based products. These products will be launched under the brand name “BeniHemp” and are intended to be distributed through convenience stores. The partnership aims at full-scale launch of their new product series by 2018-end, while coordinating supply chain arrangements via their partners in Colorado.

Grow Your Business From Expert Advice: https://www.factmr.com/report/735/cannabidiol-market 

About US
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Rohit Bhisey
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Will FDA’s Endorsement of CBD-based Drugs Spur Cannabidiol Sales? here

News-ID: 1513250 • Views: 429

More Releases from Fact.MR

In terms of Value, Passenger Cars among Vehicles Type Segments will Account for …
In terms of volume, the global automotive exhaust sensor market will record a CAGR of 3.5% during the forecast period 2017 to 2026, as projected by a recent Fact.MR report. Nearly US$ 2,000 Mn worth of automotive exhaust sensors are estimated to be sold globally by 2026-end. Miniaturization of integrated circuits has been providing a boost to the development of the automotive exhaust sensors since the recent past. Demand for microelectromechanical system
Wheel Alignment Systems among Equipment Type to Gain Lion’s Share of the Wheel …
Increasing sales of automobiles has instrumented an upsurge in demand for equipment that properly maintain the vehicles and service their key parts such as wheels and tires. Garage owners are installing advanced wheel and tire service equipment to capitalize on growing wheel replacement rate and the degrading quality of tires. Customization needs of vehicle owners is another factor driving the demand for wheel and tire service equipment. Fact.MR’s latest forecast
North America to Account for Largest Revenues in the Lifesciences Data Mining a …
The global healthcare data mining & visualization market has been slated to reflect a spectacular rise between the forecast period 2017 and 2026. The market has been estimated to surpass US$ 6,000 Mn in revenues by 2026-end. Companies Leveraging Lifesciences Data Visualization to Make Improvements in their Facilities With the business of lifesciences witnessing continuous evolution, optimizing effectiveness of decisions related to capital investment is gaining paramount importance within the industries. The decisions
Automotive Headliners Market- How are Premium Car Sales Influencing Market Deve …
Automotive headliners are composite materials that are optimized to improve safety in automobiles in terms of head impact, or alternatively to incorporate additional LED lighting films in the fabric. Numerous headliner products comprise tricot knit fabrics that are napped to provide vehicle passengers a soft texture and uniform aesthetics. The fabric is adhered to melted polyurethane foam in most cases. More than 95% demand is for hardtop automotive headliners across

All 5 Releases


More Releases for CBD

Jolly CBD Oil Review-Does Jolly CBD Work-Complete Info
There is a press release, dated January 19, 2021, regarding the system. According to the click release, “Nowadays continual sicknesses, most cancers, cardiovascular issues have turn out to be so famous that human beings had been finding ways to therapy such illnesses in a natural way. CBD products have end up famous in such regards so that the customers can get herbal remedy. Jolly CBD is one such product
Herbal Grown CBD-Does Herbal Grown CBD- Work-Complete Info
I want to clean that this is often a financially savvy item, and gives you first rate fee and boundaries. You’ll find the continuing price of this Herbal Grown CBD Oil at the reliable website. Herbal Grown CBD Oil does a exceptional task handing over all the health blessings CBD is known to provide. It may be ate up to alleviate persistent ache, strain, and anxiety and regulate sleep cycles, combat
Rebalance CBD Oil Reviews-Does Rebalance CBD Work-Complete Info
A lot of people are speaking about CBD and what it is able to do for human health, and there’s a great motive for that. It actually can do a exceptional deal of true. Today, we’re going to inform you approximately a brand new tincture referred to as Rebalance CBD Oil! This new tincture is right here to supply all the advantages of CBD to every person who desires them.
Harrelsons Own CBD-Does Harrelsons Own CBD Work-Complete Info
Harrelsons Own CBD is a complement that offers consumers the advantages of a full-spectrum CBD in a water soluble treatment to promote speedy absorption. The product can be bought from the reliable website, where it's far to be had in multi-packs for a higher rate. http://claimspecialdiscount.site/Get-HarrelsonsOwnCBD-Now What is Harrelsons Own CBD? CBD, or cannabidiol, is developing in recognition for the reason that passing of the 2018 Farm Bill. The substance is known
CBD Gummies Market 2029 | Reliva CBD Wellness, Medix CBD, Green Roads CBD, Pure …
Global CBD Gummies Market: Overview Legal permission to use cannabis for medicinal as well as recreational purposes is working as a key driver for the growth of the global CBD gummies market. The market for CBD gummies is foreseen to register high growth trajectory during the forecast period of 2019 to 2027. As CBD gummies are non-psychotropic, their consumption does not give highness to consumers. The upcoming report on the global CBD
Grassroots Harvest introduces newest CBD product: PEARL CBD personal lubricant
AUSTIN, TX: Grassroots Harvest is proud to introduce our newest CBD product: PEARL, a groundbreaking CBD-infused water-based lubricant that’s designed for female comfort and pleasure (and guys will love it, too!) PEARL was designed by a woman with women’s health in mind, but everyone can enjoy the benefits of this CBD lube. Why CBD & Lube? Intimacy is maximized with a CBD lubricant, as tension & discomfort melt away to make room for